[Reduction of myocardial occlusion-reperfusion necrosis by the administration of a stable prostacyclin analog in the rabbit].
Golino
P
P
Tritto
I
I
Vallone
C
C
Prota
S
S
Salvatore
M
M
Chiariello
M
M
D000818:Animals; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D004353:Drug Evaluation, Preclinical; D011464:Epoprostenol / Q000627:therapeutic use*; D006321:Heart / Q000000981:diagnostic imaging; D016285:Iloprost; D009203:Myocardial Infarction / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D009206:Myocardium / Q000473:pathology; D009336:Necrosis; D011817:Rabbits; D011877:Radionuclide Imaging; D013668:Technetium Tc 99m Aggregated Albumin
D002317:Cardiovascular Agents; D013668:Technetium Tc 99m Aggregated Albumin; D011464:Epoprostenol; D016285:Iloprost
Riduzione della necrosi miocardica da occlusione-riperfusione mediante somministrazione di un analogo stabile della prostaciclina nel coniglio.